2022
DOI: 10.1177/15266028221091887
|View full text |Cite
|
Sign up to set email alerts
|

Inferior Mesenteric Artery Embolization Reduced the Incidence of Persistent Type 2 Endoleak and Related Reintervention After EVAR Without Promoting Aneurysm Shrinkage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Pre-embolization for the IMA or aneurysm sac in high-risk patients seems to be of greater benefit ( 14 , 47 , 48 ), and it could suppress aneurysm sac expansion and reduce the reintervention rate. A network meta-analysis ( 49 ) suggested that IMA embolization demonstrated benefits in achieving long-term aneurysm sac stability and lowering the risk of secondary surgery.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pre-embolization for the IMA or aneurysm sac in high-risk patients seems to be of greater benefit ( 14 , 47 , 48 ), and it could suppress aneurysm sac expansion and reduce the reintervention rate. A network meta-analysis ( 49 ) suggested that IMA embolization demonstrated benefits in achieving long-term aneurysm sac stability and lowering the risk of secondary surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Although our study did not find a statistical correlation between ILA and T2ELs, T2ELs caused by ILA still deserve attention. Pre-embolization for the IMA or aneurysm sac in high-risk patients seems to be of greater benefit (14,47,48), and it could suppress aneurysm sac expansion and reduce the reintervention rate. A network meta-analysis (49) suggested that IMA embolization demonstrated benefits in achieving long-term However, Kontopodis et al (50) in their meta-analysis that included four random studies, suggested that preemptive embolization confers no clinical benefits in EVAR, but their data were limited and had low certainty.…”
Section: Discussionmentioning
confidence: 99%